Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
Abstract
:1. Introduction
2. The Complex Issue of the New Psychoactive Substances (NPS)
3. The Deep Web and the Surface Web: Market Resilience
4. Sharing Information: Drug Fora and YouTube
5. Social Networks and Smartphone Apps
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Miliano, C.; Serpelloni, G.; Rimondo, C.; Mereu, M.; Marti, M.; De Luca, M.A. Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Front. Neurosci. 2016, 10, 1–21. [Google Scholar] [CrossRef] [PubMed]
- United Nations Office on Drugs and Crime (UNODC). World Drug Report; UNODC: Vienna, Austria, 2016; ISBN 9789211482867. [Google Scholar]
- United Nations Office on Drugs and Crime (UNODC). World Drug Report; Booklet4; UNODC: Vienna, Austria, 2017; ISBN 978-92-1-148296-6. [Google Scholar]
- Understanding the Synthetic Drug Market: The NPS Factor. Available online: https://www.unodc.org/documents/scientific/Global_Smart_Update_2018_Vol.19.pdf (accessed on 29 June 2018).
- Seely, K.A.; Lapoint, J.; Moran, J.H.; Fattore, L. Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39, 234–243. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Luca, M.A.; Bimpisidis, Z.; Melis, M.; Marti, M.; Caboni, P.; Valentini, V.; Margiani, G.; Pintori, N.; Polis, I.; Marsicano, G.; et al. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. Neuropharmacology 2015, 99, 705–714. [Google Scholar] [CrossRef] [PubMed]
- Corazza, O.; Valeriani, G.; Bersani, F.S.; Corkery, J.; Martinotti, G.; Bersani, G.; Schifano, F. “Spice”, “kryptonite”, “black mamba”: An overview of brand names and marketing strategies of novel psychoactive substances on the web. J. Psychoact. Drugs 2014, 46, 287–294. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Burns, L.; Roxburgh, A.; Bruno, R.; Van Buskirk, J. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia. Drug Test Anal. 2014, 6, 840–845. [Google Scholar] [CrossRef] [PubMed]
- De Luca, M.A.; Solinas, M.; Bimpisidis, Z.; Goldberg, S.R.; Di Chiara, G. Cannabinoidfacilitation of behavioral and biochemical hedonic taste responses. Neuropharmacology 2012, 63, 161–168. [Google Scholar] [CrossRef] [PubMed]
- Nuove Sostanze Psicoattive (NSP): Schede Tecniche Relative Alle Molecole Registrate dal Sistema Nazionale di Allerta Precoce. Available online: http://www.dronet.org/pubblicazioni_new/pubb_det.php?id=690 (accessed on 29 June 2018).
- Smith, J.P.; Sutcliffe, O.B.; Banks, C.E. An overview of recent developments in the analytical detection of new psychoactive substances (NPSs). Analyst 2015, 140, 4932–4948. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fattore, L.; Fratta, W. Beyond THC: The New Generation of Cannabinoid Designer Drugs. Front. Behav. Neurosci. 2011, 5, 60. [Google Scholar] [CrossRef] [PubMed]
- Schmidt, M.M.; Sharma, A.; Schifano, F.; Feinmann, C. “Legal highs” on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci. Int. 2011, 206, 92–97. [Google Scholar] [CrossRef] [PubMed]
- Ramo, D.E.; Popova, L.; Grana, R.; Zhao, S.; Chavez, K. Cannabis Mobile Apps: A Content Analysis. JMIR mHealth uHealth 2015, 3, e81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bierut, T.; Krauss, M.J.; Sowles, S.J.; Cavazos-Rehg, P.A. Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory. Prev. Sci. 2017, 18, 183–192. [Google Scholar] [CrossRef] [PubMed]
- United Nations Office on Drugs and Crime (UNODC). World Drug Report 2014; UNODC: Vienna, Austria, 2014; Volume 3, ISBN 9789211482775. [Google Scholar]
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report. Trends and Developments; EMCDDA: Lisbon, Portugal, 2015; ISBN 9789291686117. [Google Scholar]
- Papanti, D.; Schifano, F.; Botteon, G.; Bertossi, F.; Mannix, J.; Vidoni, D.; Impagnatiello, M.; Pascolo-Fabrici, E.; Bonavigo, T. “Spiceophrenia”: A systematic overview of “spice”-related psychopathological issues and a case report. Hum. Psychopharmacol. 2013. [Google Scholar] [CrossRef] [PubMed]
- Fattore, L. Synthetic cannabinoids-further evidence supporting the relationship between cannabinoids and psychosis. Biol. Psychiatry 2016, 79, 539–548. [Google Scholar] [CrossRef] [PubMed]
- Fantegrossi, W.E.; Wilson, C.D.; Berquist, M.D. Pro-psychotic effects of syntheticcannabinoids: Interactions with central dopamine, serotonin, and glutamate systems. Drug Metab. Rev. 2018, 50, 65–73. [Google Scholar] [CrossRef] [PubMed]
- Ferreri, F.; Bourla, A.; Mouchabac, S.; Karila, L. E-addictology: An overview of new technologies for assessing and intervening in addictive behaviors. Front. Psychiatry 2018, 9, 51. [Google Scholar] [CrossRef] [PubMed]
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The Internet and Drug Markets; EMCDDA: Lisbon, Portugal, 2016; ISBN 9789291688418. [Google Scholar]
- Harper, S.; Strumpf, E.C.; Kaufman, J.S. Do Medical Marijuana Laws Increase Marijuana Use? Replication Study and Extension. Ann. Epidemiol. 2012, 22, 207–212. [Google Scholar] [CrossRef] [PubMed]
- De Luca, M.A.; Di Chiara, G.; Cadoni, C.; Lecca, D.; Orsolini, L.; Papanti, D.; Corkery, J.; Schifano, F. Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update. CNS Neurol. Disord. Drug Targets 2017, 16, 598–609. [Google Scholar] [CrossRef] [PubMed]
- Cerdá, M.; Wall, M.; Keyes, K.M.; Galea, S.; Hasin, D. Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 2012, 120, 22–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- D’Amico, E.J.; Miles, J.N.; Tucker, J.S. Gateway to curiosity: Medical marijuana adsand intention and use during middle school. Psychol. Addict. Behav. 2015, 29, 613–619. [Google Scholar] [CrossRef] [PubMed]
- Van Hout, M.C.; Bingham, T. Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. Int. J. Drug Policy 2014, 25, 183–189. [Google Scholar] [CrossRef] [PubMed]
- AlQahtani, A.A.; El-Alfy, E.-S.M. Anonymous Connections Based on Onion Routing: A Review and a Visualization Tool. Procedia Comput. Sci. 2015, 52, 121–128. [Google Scholar] [CrossRef]
- Martin, J. Drugs on the Dark Net; Palgrave Macmillan UK: London, UK, 2014; ISBN 978-1-349-48566-6. [Google Scholar]
- Christin, N. Traveling the Silk Road: A measurement analysis of a large anonymous online marketplace. arXiv, 2012; arXiv:1207.7139. [Google Scholar]
- Orsolini, L.; Papanti, D.; Corkery, J.; Schifano, F. An insight into the deep web; why it matters for addiction psychiatry? Hum. Psychopharmacol. 2017, 32, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Rhumorbarbe, D.; Staehli, L.; Broséus, J.; Rossy, Q.; Esseiva, P. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data. Forensic Sci. Int. 2016, 267, 173–182. [Google Scholar] [CrossRef] [PubMed]
- Van Hout, M.C.; Hearne, E. New psychoactive substances (NPS) on cryptomarketfora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Int. J. Drug Policy 2017, 40, 102–110. [Google Scholar] [CrossRef] [PubMed]
- Dolliver, D.S. Evaluating drug trafficking on the Tor Network: Silk Road 2, the sequel. Int. J. Drug Policy 2015, 26, 1113–1123. [Google Scholar] [CrossRef] [PubMed]
- Schifano, F.; Deluca, P.; Baldacchino, A.; Peltoniemi, T.; Scherbaum, N.; Torrens, M.; Farrě, M.; Flores, I.; Rossi, M.; Eastwood, D.; et al. Drugs on the web; the Psychonaut 2002 EU project. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006, 30, 640–646. [Google Scholar] [CrossRef] [PubMed]
- Wax, P.M. Just a click away: Recreational drug Web sites on the Internet. Pediatrics 2002, 109, e96. [Google Scholar] [CrossRef] [PubMed]
- Marlatt, G.A.; Witkiewitz, K. Update on Harm-Reduction Policy and Intervention Research. Annu. Rev. Clin. Psychol. 2010, 6, 591–606. [Google Scholar] [CrossRef] [PubMed]
- Chiauzzi, E.; DasMahapatra, P.; Lobo, K.; Barratt, M.J. Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Subst. Use Misuse 2013, 48, 661–670. [Google Scholar] [CrossRef] [PubMed]
- Nicholson, T.; White, J.; Duncan, D.F. A Survey of adult recreational drug use via the World Wide Web: The DRUGNET Study. J. Psychoact. Drugs 1999, 31, 415–422. [Google Scholar] [CrossRef] [PubMed]
- Baggott, M.J.; Erowid, E.; Erowid, F.; Galloway, G.P.; Mendelson, J. Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug Alcohol Depend. 2010, 111, 250–256. [Google Scholar] [CrossRef] [PubMed]
- Davey, Z.; Schifano, F.; Corazza, O.; Deluca, P. Psychonaut Web Mapping Group e-Psychonauts: Conducting research in online drug forum communities. J. Ment. Health 2012, 21, 386–394. [Google Scholar] [CrossRef] [PubMed]
- Krauss, M.J.; Sowles, S.J.; Mylvaganam, S.; Zewdie, K.; Bierut, L.J.; Cavazos-Rehg, P.A. Displays of dabbing marijuana extracts on YouTube. Drug Alcohol Depend. 2015, 155, 45–51. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krauss, M.J.; Sowles, S.J.; Stelzer-Monahan, H.E.; Bierut, T.; Cavazos-Rehg, P.A. “It Takes Longer, but When It Hits You It Hits You!”: Videos About Marijuana Edibles on YouTube. Subst. Use Misuse 2017, 52, 709–716. [Google Scholar] [CrossRef] [PubMed]
- Manning, P. YouTube, “drug videos” and drugs education. Drugs Edu. Prev. Policy 2013, 20, 120–130. [Google Scholar] [CrossRef]
- Lau, A.Y.S.; Gabarron, E.; Fernandez-Luque, L.; Armayones, M. Social media in health—What are the safety concerns for health consumers? Health Inf. Manag. 2012, 41, 30–35. [Google Scholar] [CrossRef] [PubMed]
- Nielsen. Nielsen Reports and Insights. The Social Media Report 2012. Available online: http://www.nielsen.com/us/en/insights/reports/2012/state-of-the-media-the-social-media-report-2012.html (accessed on 22 February 2018).
- Cavazos-Rehg, P.A.; Krauss, M.J.; Sowles, S.J.; Bierut, L.J. Marijuana-Related Posts on Instagram. Prev. Sci. 2016, 17, 710–720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Drugabuse.com. Instagram Drug Dealers. Available online: https://drugabuse.com/featured/instagram-drug-dealers/ (accessed on 22 February 2018).
- Simpson, S.S.; Adams, N.; Brugman, C.M.; Conners, T.J. Detecting Novel and Emerging Drug Terms Using Natural Language Processing: A Social Media Corpus Study. JMIR Public Health Surveill. 2018, 4, e2. [Google Scholar] [CrossRef] [PubMed]
- Kolliakou, A.; Ball, M.; Derczynski, L.; Chandran, D.; Gkotsis, G.; Deluca, P.; Jackson, R.; Shetty, H.; Stewart, R. Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records. Eur. Psychiatry 2016, 38, 15–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Orsolini, L.; Papanti, G.D.; Francesconi, G.; Schifano, F. Mind Navigators of Chemicals’ Experimenters? A Web-Based Description of E.-Psychonauts. Cyberpsychol. Behav. Soc. Netw. 2015, 18, 296–300. [Google Scholar] [CrossRef] [PubMed]
- Bindhim, N.F.; Naicker, S.; Freeman, B.; Mcgeechan, K.; Trevena, L. Apps Promoting Illicit Drugs-A Need for Tighter Regulation? J. Consum. Health Internet 2014, 18, 31–43. [Google Scholar] [CrossRef]
- Baumann, M.H.; Bukhari, M.O.; Lehner, K.R.; Anizan, S.; Rice, K.C.; Concheiro, M.; Huestis, M.A. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Curr. Top. Behav. Neurosci. 2016, 32, 93–117. [Google Scholar]
- Davidson, C.; Opacka-Juffry, J.; Arevalo-Martin, A.; Garcia-Ovejero, D.; Molina-Holgado, E.; Molina-Holgado, F. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids from Structure to Adverse Events. Adv. Pharmacol. 2017, 80, 135–168. [Google Scholar] [CrossRef] [PubMed]
- Karila, L.; Lafaye, G.; Scocard, A.; Cottencin, O.; Benyamina, A. MDPV and α-PVP use in humans: The twisted sisters. Neuropharmacology 2017. [Google Scholar] [CrossRef] [PubMed]
- Pintori, N.; Loi, B.; Mereu, M. Synthetic cannabinoids: The hidden side of Spice drugs. J. Emerg. Nurs. 2017, 37, 292–293. [Google Scholar] [CrossRef] [PubMed]
- Weinstein, A.M.; Rosca, P.; Fattore, L.; London, E.D. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Front. Psychiatry 2017, 8, 156. [Google Scholar] [CrossRef] [PubMed]
- Zanda, M.T.; Fattore, L. Old and new synthetic cannabinoids: Lessons from animal models. Drug Metab. Rev. 2018, 50, 54–64. [Google Scholar] [CrossRef] [PubMed]
- Zanda, M.T.; Fadda, P.; Chiamulera, C.; Fratta, W.; Fattore, L. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects. Behav. Pharmacol. 2016, 27, 489–496. [Google Scholar] [CrossRef] [PubMed]
- Zawilska, J.B. An Expanding World of Novel Psychoactive Substances: Opioids. Front. Psychiatry 2017, 8, 110. [Google Scholar] [CrossRef] [PubMed]
- Loi, B.; Zloh, M.; De Luca, M.A.; Pintori, N.; Corkery, J.; Schifano, F. 4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study. Hum. Psychopharmacol. 2017, 32. [Google Scholar] [CrossRef] [PubMed]
- Pinterova, N.; Horsley, R.R.; Palenicek, T. Synthetic Aminoindanes: A Summary of Existing Knowledge. Front. Psychiatry 2017, 8, 236. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Miliano, C.; Margiani, G.; Fattore, L.; De Luca, M.A. Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps. Brain Sci. 2018, 8, 123. https://doi.org/10.3390/brainsci8070123
Miliano C, Margiani G, Fattore L, De Luca MA. Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps. Brain Sciences. 2018; 8(7):123. https://doi.org/10.3390/brainsci8070123
Chicago/Turabian StyleMiliano, Cristina, Giulia Margiani, Liana Fattore, and Maria Antonietta De Luca. 2018. "Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps" Brain Sciences 8, no. 7: 123. https://doi.org/10.3390/brainsci8070123
APA StyleMiliano, C., Margiani, G., Fattore, L., & De Luca, M. A. (2018). Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps. Brain Sciences, 8(7), 123. https://doi.org/10.3390/brainsci8070123